Citigroup: MGM China (02282) first-quarter property EBITDA exceeds expectations, maintaining a "buy" rating.
The management expects the company's expenses (excluding equity incentives) for the year 2026 to be approximately 45 to 50 million US dollars, lower than the previous guidance.
Citigroup released a research report stating that it maintains a "buy" rating on MGM China (02282) with a target price of HK$17.3, and expects that its new gaming and non-gaming facilities will help MGM China defend its market share in the 2026 fiscal year. MGM China's first quarter property EBITDA reached 2.458 billion yuan, a year-on-year increase of 4%, exceeding the bank's and market's expectations by 5% to 6%, mainly due to effective cost control by management. Although the VIP win rate at MGM Macau was significantly below normal levels (only 0.6%), the first quarter property EBITDA profit margin remained stable at 28%.
Management emphasized that the current scale of operating expenses is in line with growth and that the profit margin is sustainable. 100 suites at MGM Macau will be renovated. Management expects corporate spending in 2026 (excluding stock incentives) to be approximately $45 million to $50 million, lower than previous guidance.
Related Articles

FOUNDER HOLD (00418) spent 109,500 Hong Kong dollars to repurchase 150,000 shares on April 30th.

Shanghai Fosun Pharmaceutical (600196.SH) subsidiary's nitroglycerin injection receives registration approval.

The chairman of Tianjin Benefo Tejing Electric (600468.SH) has been changed to Zhang Jianxin.
FOUNDER HOLD (00418) spent 109,500 Hong Kong dollars to repurchase 150,000 shares on April 30th.

Shanghai Fosun Pharmaceutical (600196.SH) subsidiary's nitroglycerin injection receives registration approval.

The chairman of Tianjin Benefo Tejing Electric (600468.SH) has been changed to Zhang Jianxin.

RECOMMEND





